Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

High Content Screening Market: Business Growth, Development Factors, Application and Future Prospects

 



(Medical-NewsWire.com, November 13, 2018 ) According to the new market research report “High Content Screening Market by Product (Cell Imaging & Analysis System, Flow Cytometry, Consumable, Software, Service) Application (Primary & Secondary Screening, Toxicity Studies, Target Identification & Validation), End User - Global Forecast to 2022", published by MarketsandMarkets™,The global high-content screening market is expected to reach USD 909.0 Million by 2022 from USD 557.1 Million in 2017, at a CAGR of 10.3%. 



Don’t miss out on business opportunities in High Content Screening Market. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2z3G8oc

Early buyers will receive 10% customization on reports.



The conventional method of toxicity studies involves the screening of large libraries in search of potential drug candidates. This method is expensive, resource- & time-consuming, and has a low success rate. Hence, HCS solutions for testing the potential toxicity of chemicals and complex substances are being adopted by pharmaceutical companies to improve in vitro toxicity testing by reducing the time and cost. The need for cost containment in pharma R&D, advancements in informatics solutions and imaging instruments, and government funding and venture capital investments across developed markets are the major factors driving the growth of the high-content screening (HCS) market.  The increasing number of contract research organizations providing HCS outsourcing services, and application of HCS in personalized medicine, present significant growth opportunities in the market. The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022.



Market Dynamics

Drivers

Need for cost containment in pharma R&D

Government funding and venture capital investments across developed markets

Advancements in informatics solutions and imaging instruments

Restraint

Lower adoption of HCS instruments due to their high prices

Opportunities

Increasing number of CROs providing HCS services

Application of HCS in personalized medicine

Challenges

Dearth of knowledgeable and skilled operators of HCS instruments

Inadequate infrastructure and funding for R&D in emerging countries

Advancements in informatics solutions and imaging instruments drives the global high content screening market

Over the last few years, the HCS market has witnessed significant developments in the quality of cell imaging instruments and imaging analysis solutions. For instance, the Cell Insight CX7 high-content analysis platform, launched by Thermo Fisher Scientific, Inc. in January 2016, is an integration of wide-field and confocal imaging that enables seven-color excitation and laser autofocus. Moreover, various cell analyzers and cell sorters have also been introduced in the market. In December 2015, Becton, Dickinson and Company launched the BD FACSCelesta cell analyzer that offers the simultaneous measurement of up to 14 different single-cell characteristics. These technologically advanced products have enabled researchers to carry out cell image analysis with increased efficiency and reduced costs.

Browse and in-depth TOC on “High Content Screening Market”

138 - Tables



42 - Figures



166 - Pages



 



View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html



The HCS market is highly competitive in nature. The prominent players in the global high-content screening market are GE Healthcare (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Tecan Group (Switzerland), BioTek Instruments Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Yokogawa Electric Corporation (Japan), and Merck Millipore (U.S.).



Request for Free Sample Report @ http://bit.ly/2PVTMDg



Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting

About MarketsandMarkets™



MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.



Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.



MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.



Contact:



Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email: sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/high-content-screening-market.asp

Visit Our Website: https://www.marketsandmarkets.com

MarketsandMarkets

Mr. Shelly Singh

1-888-600-6441

sales@marketsandmarkets.com

Source: EmailWire.Com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC